Regular publication has been halted for an indefinite period.

DBH invests HUF 80m in Hungarian hygiene product Hand-in-Scan

DBH Investments has invested HUF 80 million in Clariton Ltd., the developers of Hand-in-Scan, medical hygiene tool that checks the efficiency of hand sterilization in the hospital environment. The product had previously won the LISAvienna MedTech Award for 2012.

Clariton Ltd., based in Debrecen, is a Hungarian developer of the biomedical equipment Hand-in-Scan, that uses ultra-violet light and digital imaging to visualize the effectiveness of hand-washing in medical environments. It highlights disinfected versus unaffected areas after hand rubbing, and provide an overall quality score to ascertain the effectiveness of hand-washing.

The company’s product is being presented at a time when hand hygiene compliance in developed nations is a dismal 50 per cent, indicating the huge potential for such a device in the medical sector. Statistics show that over 90,000 deaths in America and 15,000 in Europe originate from Hospital-acquired Infections, or HAI. Through this innovative, patented solution, the hospital staff can acquire better hand hygiene practice that leads to reduced rate of infection.

The Hand-In-Scan team has previously won the Innovact Campus Award, the ICPIC Innovation Academy, the ACES Young Innovation Award, and the Best of Biotech award. The project graduated from the European Entrepreneurship Foundation’s Venture Accelerator course. The Austrian Center for Medical Innovation and Technology (ACMIT) and the Budapest University of Technology and Economics (BME) are key development partners of the project. The JEREMIE program winner DBH Investment is providing seed capital investment supporting the commercialization of the technology within a year.


 
 
CC BY NC SA